Danaher Corporation (NYSE:DHR) Shares Purchased by Huntleigh Advisors Inc.

Huntleigh Advisors Inc. raised its holdings in Danaher Corporation (NYSE:DHR) by 0.5% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 12,356 shares of the conglomerate’s stock after buying an additional 64 shares during the quarter. Huntleigh Advisors Inc.’s holdings in Danaher were worth $2,533,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of DHR. GHP Investment Advisors Inc. increased its holdings in shares of Danaher by 396.0% during the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock worth $25,000 after buying an additional 99 shares during the last quarter. Heck Capital Advisors LLC purchased a new position in shares of Danaher in the 4th quarter worth about $27,000. Smallwood Wealth Investment Management LLC acquired a new position in shares of Danaher in the 1st quarter valued at about $31,000. Rialto Wealth Management LLC purchased a new stake in shares of Danaher during the 4th quarter worth about $34,000. Finally, Hurley Capital LLC acquired a new stake in Danaher during the 4th quarter worth approximately $34,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insider Transactions at Danaher

In other news, Chairman Steven M. Rales sold 1,250,000 shares of the stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $196.74, for a total value of $245,925,000.00. Following the completion of the transaction, the chairman directly owned 3,105,808 shares in the company, valued at $611,036,665.92. This trade represents a 28.70% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Christopher Paul Riley sold 15,805 shares of the company’s stock in a transaction that occurred on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total value of $3,129,390.00. Following the completion of the sale, the executive vice president owned 15,179 shares of the company’s stock, valued at $3,005,442. This trade represents a 51.01% decrease in their ownership of the stock. The disclosure for this sale can be found here. 11.10% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on DHR shares. Jefferies Financial Group decreased their target price on Danaher from $260.00 to $230.00 and set a “buy” rating for the company in a research report on Tuesday, April 22nd. Citigroup restated a “buy” rating on shares of Danaher in a report on Monday, April 7th. UBS Group dropped their price objective on shares of Danaher from $275.00 to $240.00 and set a “buy” rating on the stock in a research note on Wednesday, April 23rd. JPMorgan Chase & Co. decreased their target price on shares of Danaher from $280.00 to $260.00 and set an “overweight” rating for the company in a research note on Tuesday, April 22nd. Finally, Evercore ISI dropped their price target on shares of Danaher from $240.00 to $230.00 and set an “outperform” rating on the stock in a research note on Tuesday, April 22nd. Four equities research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $248.61.

Danaher Trading Up 0.3%

Shares of NYSE:DHR opened at $203.08 on Friday. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $281.70. The company has a quick ratio of 1.05, a current ratio of 1.43 and a debt-to-equity ratio of 0.31. The company has a market cap of $145.33 billion, a PE ratio of 39.43, a P/E/G ratio of 2.84 and a beta of 0.77. The company’s 50-day moving average price is $195.52 and its 200 day moving average price is $207.59.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.62 by $0.26. The business had revenue of $5.74 billion during the quarter, compared to analyst estimates of $5.58 billion. Danaher had a return on equity of 10.80% and a net margin of 15.81%. Sell-side analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be paid a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.63%. Danaher’s payout ratio is 24.85%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.